Hyperlipoproteinemia as a risk factor for ischemic heart disease.

We analyzed serum lipoproteins and apolipoprotein E (apo E) from 199 patients in CCU, having ischemic heart disease, and from 211 healthy subjects. It was suggested that serum lipoprotein abnormalities, especially elevated low density lipoprotein (LDL) levels, are closely related to atherogenesis in relatively young patients and subjects with severe coronary lesions. The frequency of apo E-4 was higher and that of E-2 was lower in the CCU group than in the control group. Apo E mutants, E-7 (Glu244----Lys, Glu245----Lys) and E-5 (Glu3 (Glu3----Lys), were also frequent in the CCU group. Apo E isoproteins have higher pI in the order E-2, E-3, E-4, and we observed that LDL-cholesterol levels increased in the same order. The apo E mutants, E-5 and E-7, are also more basic than E-4. These findings suggest that basic apo Es were associated with the development of atherosclerosis. The prevalence of familial hypercholesterolemia (FH) in the CCU group was more than 10 times higher than the reported frequency of FH heterozygotes in normal population. The persistence of marked hypercholesterolemia from infancy probably makes FH patients susceptible to atherosclerosis. Based on the analysis of LDL-receptor protein synthesis, various types of mutations were observed even in phenotypically homozygous FH patients. FH homozygotes were divided into 2 groups, a receptor-negative group and a receptor-defective group. We found a great difference in the frequency of coronary heart disease depending on whether even a small number of receptors were present or not.

[1]  M. Menju,et al.  Analysis of apolipoprotein E7 (apolipoprotein E-Suita) gene from a patient with hyperlipoproteinemia. , 1989, Journal of biochemistry.

[2]  T. Funahashi,et al.  Clinical features of familial hypercholesterolemia. , 1989, Arteriosclerosis.

[3]  A. Yamamoto,et al.  Analysis of apolipoprotein E5 gene from a patient with hyperlipoproteinemia. , 1988, Journal of biochemistry.

[4]  R. Mahley,et al.  Plasma lipoproteins: apolipoprotein structure and function. , 1984, Journal of lipid research.

[5]  T. Sumiyoshi,et al.  New mutants of apolipoprotein E associated with atherosclerotic diseases but not to type III hyperlipoproteinemia. , 1984, The Journal of clinical investigation.

[6]  A. Yamamoto,et al.  A new isoform of apolipoprotein E--apo E-5--associated with hyperlipidemia and atherosclerosis. , 1984, Atherosclerosis.

[7]  R. Mahley,et al.  Lipoprotein receptors and cholesterol homeostasis. , 1983, Biochimica et biophysica acta.

[8]  J. Goldstein,et al.  Posttranslational processing of the LDL receptor and its genetic disruption in familial hypercholesterolemia , 1982, Cell.

[9]  M. Brown,et al.  The LDL receptor defect in familial hypercholesterolemia. Implications for pathogenesis and therapy. , 1982, The Medical clinics of North America.

[10]  D. Jacobs,et al.  Lipoprotein‐Cholesterol Distributions in Selected North American Populations: The Lipid Research Clinics Program Prevalence Study , 1980, Circulation.

[11]  G. Utermann,et al.  Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man , 1977, Nature.

[12]  M C Hjortland,et al.  High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. , 1977, The American journal of medicine.